Alcon acquires Neurotech Pharmaceuticals for $550M

Alcon has acquired Neurotech Pharmaceuticals for $550 million.

Detected & updated continuously · Source: Nebula

Story subjects

Alcon Inc.Neurotech Pharmaceuticals

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula